Denatonium Recruiting Phase 2 Trials for Prader-Willi Syndrome Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05153434
A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome